IDGenetics: a comprehensive database for genes and mutations of intellectual disability related disorders

Neuroscience Letters

Volumn 685, Issue , 2018, Pages 96-101

  Chen, Chong ^a   Chen, Denghui ^b   Xue, Huangqi ^b   Liu, Xinting ^b   Zhang, Tao ^b   Tang, Shaohua ^a,b   Li, Wei ^b   Xu, Xueqin ^a  

^a WENZHOU CENTRAL HOSPITAL   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Developmental brain disorders; Gene Disease Phenotype network; Intellectual disability; Overlap analysis

Indexed keywords

ANK3 PROTEIN; CNNM2 PROTEIN; DPYD PROTEIN; KIF5C PROTEIN; METHYL CPG BINDING PROTEIN 2; MICRORNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; NIPBL PROTEIN; NRXN1 PROTEIN; NT5C2 PROTEIN; PERICENTRIN; SMARCA3 PROTEIN; STT3A PROTEIN; TBX1 PROTEIN; TRANSCRIPTION FACTOR 4; UNCLASSIFIED DRUG;

ARTICLE; BRAIN DISEASE; COMORBIDITY; COPY NUMBER VARIATION; DEVELOPMENTAL DISORDER; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC VARIABILITY; HUMAN; INDEL MUTATION; INTELLECTUAL IMPAIRMENT; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; NEUROPATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; MALE; MUTATION;

DNA COPY NUMBER VARIATIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INTELLECTUAL DISABILITY; MALE; MUTATION; PHENOTYPE;

EID: 85052288798     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2018.08.027     Document Type: Article

References (55)

1. Maulik, P.K., et al. Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil 32 (2011), 419–436.
2. Mehregan, H., Najmabadi, H., Kahrizi, K., Genetic Studies in Intellectual Disability and Behavioral Impairment. Arch Iran Med 19 (2016), 363–375.
3. Kaufman, L., Ayub, M., Vincent, J.B., The genetic basis of non-syndromic intellectual disability: a review. J Neurodev Disord 2 (2010), 182–209.
4. Kim, K.C., et al. MeCP2 Modulates Sex Differences in the Postsynaptic Development of the Valproate Animal Model of Autism. Mol Neurobiol 53 (2016), 40–56.
5. Strauss, K.A., et al. CODAS syndrome is associated with mutations of LONP1, encoding mitochondrial AAA+ Lon protease. Am J Hum Genet 96 (2015), 121–135.
6. Matson, J.L., Shoemaker, M., Intellectual disability and its relationship to autism spectrum disorders. Res Dev Disabil 30 (2009), 1107–1114.
7. Srivastava, A.K., Schwartz, C.E., Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms. Neurosci Biobehav Rev 46:Pt 2 (2014), 161–174.
8. Tuchman, R., Moshe, S.L., Rapin, I., Convulsing toward the pathophysiology of autism. Brain Dev 31 (2009), 95–103.
9. Harel, T., et al. Monoallelic and Biallelic Variants in EMC1 Identified in Individuals with Global Developmental Delay, Hypotonia, Scoliosis, and Cerebellar Atrophy. Am J Hum Genet 98 (2016), 562–570.
10. Ji, J., et al. DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies. Eur J Hum Genet 23 (2015), 1473–1481.
11. Deth, R.C., Genomics, intellectual disability, and autism. N Engl J Med 366 (2012), 2231–2232 author reply 2232.
12. Gonzalez-Mantilla, A.J., et al. A Cross-Disorder Method to Identify Novel Candidate Genes for Developmental Brain Disorders. JAMA Psychiatry 73 (2016), 275–283.
13. D'Angelo, D., et al. Defining the Effect of the 16p11.2 Duplication on Cognition, Behavior, and Medical Comorbidities. JAMA Psychiatry 73 (2016), 20–30.
14. Tropeano, M., Andrieux, J., Collier, D.A., Clinical utility gene card for: 16p13.11 microdeletion syndrome. Eur J Hum Genet, 2014, 22.
15. Xu, L.M., et al. AutismKB: an evidence-based knowledgebase of autism genetics. Nucleic Acids Res 40 (2012), D1016–1022.
16. Ran, X., et al. EpilepsyGene: a genetic resource for genes and mutations related to epilepsy. Nucleic Acids Res 43 (2015), D893–899.
17. Zhang, L., et al. ADHDgene: a genetic database for attention deficit hyperactivity disorder. Nucleic Acids Res 40 (2012), D1003–1009.
18. Jia, P., et al. SZGR 2.0: a one-stop shop of schizophrenia candidate genes. Nucleic Acids Res 45 (2017), D915–D924.
19. Li, J., et al. Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database. Mol Psychiatry 21 (2016), 290–297.
20. Landrum, M.J., et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 44 (2016), D862–868.
21. Kohler, S., et al. The Human Phenotype Ontology in 2017. Nucleic Acids Res 45 (2017), D865–D876.
22. Wang, K., Li, M., Hakonarson, H., ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res, 38, 2010, e164.
23. Wang, J., et al. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res 41 (2013), W77–83.
24. Gene Ontology, C., et al. Gene Ontology annotations and resources. Nucleic Acids Res 41 (2013), D530–535.
25. Kanehisa, M., et al. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res 42 (2014), D199–205.
26. Cerami, E.G., et al. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res 39 (2011), D685–690.
27. Kelder, T., et al. WikiPathways: building research communities on biological pathways. Nucleic Acids Res 40 (2012), D1301–1307.
28. Amberger, J., Bocchini, C., Hamosh, A., A new face and new challenges for Online Mendelian Inheritance in Man (OMIM(R)). Hum Mutat 32 (2011), 564–567.
29. Blake, J.A., et al. The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse. Nucleic Acids Res 42 (2014), D810–817.
30. Coordinators, N.R., Database Resources of the National Center for Biotechnology Information. Nucleic Acids Res 45 (2017), D12–D17.
31. Genomes Project, C., et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491 (2012), 56–65.
32. Fu, W., et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 493 (2013), 216–220.
33. Kumar, P., Henikoff, S., Ng, P.C., Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4 (2009), 1073–1081.
34. Lindblad-Toh, K., et al. A high-resolution map of human evolutionary constraint using 29 mammals. Nature 478 (2011), 476–482.
35. Chun, S., Fay, J.C., Identification of deleterious mutations within three human genomes. Genome Res 19 (2009), 1553–1561.
36. Schwarz, J.M., et al. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 7 (2010), 575–576.
37. Reva, B., Antipin, Y., Sander, C., Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res, 39, 2011, e118.
38. Shihab, H.A., et al. Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum Mutat 34 (2013), 57–65.
39. Davydov, E.V., et al. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput Biol, 6, 2010, e1001025.
40. Pollard, K.S., et al. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res 20 (2010), 110–121.
41. Aguilar, J.I., et al. Neuronal Depolarization Drives Increased Dopamine Synaptic Vesicle Loading via VGLUT. Neuron 95 (2017), 1074–1088 e1077.
42. Messier, J., The Role of Neuroligins in the Cerebellum Highlights the Diversity of Synapse-Specifying Molecules. J Neurosci 37 (2017), 739–741.
43. Zhou, H., et al. MED12 mutations link intellectual disability syndromes with dysregulated GLI3-dependent Sonic Hedgehog signaling. Proc Natl Acad Sci U S A 109 (2012), 19763–19768.
44. Ba, W., van der Raadt, J., Nadif Kasri, N., Rho GTPase signaling at the synapse: implications for intellectual disability. Exp Cell Res 319 (2013), 2368–2374.
45. Kong, Y., et al. High Throughput Sequencing Identifies MicroRNAs Mediating alpha-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model. PLoS One, 10, 2015, e0137432.
46. Tillotson, R., et al. Radically truncated MeCP2 rescues Rett syndrome-like neurological defects. Nature 550 (2017), 398–401.
47. Gillespie, J.M., Hodge, J.J., CASK regulates CaMKII autophosphorylation in neuronal growth, calcium signaling, and learning. Front Mol Neurosci, 6, 2013, 27.
48. Tessier, C.R., Broadie, K., The fragile X mental retardation protein developmentally regulates the strength and fidelity of calcium signaling in Drosophila mushroom body neurons. Neurobiol Dis 41 (2011), 147–159.
49. Henry, F.E., et al. Mechanistic target of rapamycin is necessary for changes in dendritic spine morphology associated with long-term potentiation. Mol Brain, 10, 2017, 50.
50. Tian, Y., et al. Loss of FMRP Impaired Hippocampal Long-Term Plasticity and Spatial Learning in Rats. Front Mol Neurosci, 10, 2017, 269.
51. Borroni, B., et al. Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. Neurol Sci 33 (2012), 375–378.
52. Rosales-Reynoso, M.A., et al. [Alzheimer's disease and fragile X syndrome: the Wnt/ss-catenin pathway as a common biological mechanism]. Rev Neurol 55 (2012), 543–548.
53. Ruparelia, A., Pearn, M.L., Mobley, W.C., Aging and intellectual disability: insights from mouse models of Down syndrome. Dev Disabil Res Rev 18 (2013), 43–50.
54. Kanner, A.M., et al. Epilepsy as a Network Disorder (1): What can we learn from other network disorders such as autistic spectrum disorder and mood disorders?. Epilepsy Behav 77 (2017), 106–113.
55. Yu, W., et al. GAPscreener: an automatic tool for screening human genetic association literature in PubMed using the support vector machine technique. BMC Bioinformatics, 9, 2008, 205.